Clinical Trial

Direct-to-angio Approach From loCal hOspitals Based on a PoInt-of-care bLOod Test for LVO

Study acronym: COPILOT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Direct-to-angio approach from loCal hOspitals based on a PoInt-of-care bLOod Test for LVO (COPILOT) is a multi-center, prospective, cluster-randomized crossover trial that will evaluate if the triage assessment to thrombectomy puncture time is shorter after performing the LVOne testing compared to current management standards in patients with suspected large vessel occlusion.
Trial Details
NCT Number NCT06910163
Lead Sponsor Juan Vicenty
Collaborators: University of Puerto Rico, Mennonite Health System
Conditions Acute Stroke
Enrollment 520 participants
Start Date 2025-05
Primary Completion 2027-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2025-04-04